Literature DB >> 16170079

Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome.

M Arnold1, K Nedeltchev, L Remonda, U Fischer, C Brekenfeld, B Keserue, G Schroth, H P Mattle.   

Abstract

BACKGROUND: Different grading systems of arterial recanalisation have never been compared in large series of stroke patients treated with intra-arterial thrombolysis (IAT).
METHODS: Clinical and angiographic findings and outcome were analysed in 147 patients with M1 or M2 segment occlusion of the middle cerebral artery treated with IAT. Associations of the thrombolysis in myocardial infarction (TIMI) grading system and the Mori grading system with clinical outcome were compared.
RESULTS: The median NIHSS score on admission was 15 and the mean time from symptom onset to IAT was 242 minutes. After three months the outcome was favourable (defined as modified Rankin scale score (mRS) < or = 2) in 85 patients (58%) and poor (mRS 3 to 5) in 44 (30%); 18 patients (12%) were dead. Recanalisation was categorised as TIMI grade 0 in 17 patients (12%), TIMI 1 in 16 (11%), TIMI 2 in 83 (56%), and TIMI 3 in 31(21%). Seventeen patients (12%) showed Mori grade 0 reperfusion, 16 (11%) Mori 1, 37 (25%) Mori 2, 46 (31%) Mori 3, and 31 (21%) Mori 4. In both TIMI and Mori grading systems, reopening the artery was an independent predictor of a favourable clinical outcome (p < 0.0001). When recanalisation was partial, outcome was better in patients with reperfusion >50% (Mori 3) than in those with reperfusion <50% (Mori 2) (p = 0.008).
CONCLUSIONS: Both TIMI and Mori grading systems are useful for predicting outcome after stroke and IAT. When recanalisation is partial the Mori classification is more refined in giving prognostic information.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170079      PMCID: PMC1739375          DOI: 10.1136/jnnp.2004.055160

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke.

Authors:  T Ueda; S Sakaki; Y Kumon; S Ohta
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

3.  Measurements of acute cerebral infarction: a clinical examination scale.

Authors:  T Brott; H P Adams; C P Olinger; J R Marler; W G Barsan; J Biller; J Spilker; R Holleran; R Eberle; V Hertzberg
Journal:  Stroke       Date:  1989-07       Impact factor: 7.914

4.  Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.

Authors:  W Hacke; H Zeumer; A Ferbert; H Brückmann; G J del Zoppo
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

5.  Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery.

Authors:  E Mori; M Tabuchi; T Yoshida; A Yamadori
Journal:  Stroke       Date:  1988-07       Impact factor: 7.914

6.  Predictors of clinical outcome in patients receiving local intra-arterial thrombolysis without subsequent symptomatic intracranial hemorrhage against acute middle cerebral artery occlusion.

Authors:  Tatsuro Takada; Masahiro Yasaka; Kazuo Minematsu; Hiroaki Naritomi; Takenori Yamaguchi
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

7.  Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis.

Authors:  M Arnold; K Nedeltchev; G Schroth; R W Baumgartner; L Remonda; T J Loher; F Stepper; M Sturzenegger; B Schuknecht; H P Mattle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

8.  Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.

Authors:  T Neumann-Haefelin; R du Mesnil de Rochemont; J B Fiebach; A Gass; C Nolte; T Kucinski; J Rother; M Siebler; O C Singer; K Szabo; A Villringer; P D Schellinger
Journal:  Stroke       Date:  2003-12-11       Impact factor: 7.914

Review 9.  Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions.

Authors:  M Arnold; K Nedeltchev; H P Mattle; T J Loher; F Stepper; G Schroth; C Brekenfeld; M Sturzenegger; L Remonda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  17 in total

Review 1.  Revascularization grading in endovascular acute ischemic stroke therapy.

Authors:  O O Zaidat; M A Lazzaro; D S Liebeskind; N Janjua; L Wechsler; R G Nogueira; R C Edgell; J S Kalia; A Badruddin; J English; D Yavagal; J F Kirmani; A V Alexandrov; P Khatri
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

Review 2.  New stent retriever devices.

Authors:  N C Beadell; Helmi Lutsep
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

3.  Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the MERCI and Multi MERCI trials.

Authors:  J D Fields; H L Lutsep; W S Smith
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

4.  Imaging Biomarkers for Intra-arterial Stroke Therapy.

Authors:  Olvert A Berkhemer; Shervin Kamalian; R Gilberto González; Charles B L M Majoie; Albert J Yoo
Journal:  Cardiovasc Eng Technol       Date:  2013-12-01       Impact factor: 2.495

5.  Predictors of functional outcome vary by the hemisphere of involvement in major ischemic stroke treated with intra-arterial therapy: a retrospective cohort study.

Authors:  Albert J Yoo; Javier Romero; Reza Hakimelahi; Raul G Nogueira; James D Rabinov; Johnny C Pryor; R Gilberto González; Joshua A Hirsch; Pamela W Schaefer
Journal:  BMC Neurol       Date:  2010-04-23       Impact factor: 2.474

6.  MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization.

Authors:  Albert J Yoo; Luis A Verduzco; Pamela W Schaefer; Joshua A Hirsch; James D Rabinov; R Gilberto González
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

7.  Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation.

Authors:  G A Christoforidis; C Karakasis; Y Mohammad; L P Caragine; M Yang; A P Slivka
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

8.  Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation.

Authors:  Argyro Tountopoulou; Bjoern Ahl; Karin Weissenborn; Hartmut Becker; Friedrich Goetz
Journal:  Neuroradiology       Date:  2007-10-05       Impact factor: 2.804

9.  The clinical and radiographic importance of distinguishing partial from near-complete reperfusion following intra-arterial stroke therapy.

Authors:  M V Jayaraman; J A Grossberg; K M Meisel; A Shaikhouni; B Silver
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-26       Impact factor: 3.825

10.  Preliminary experience with intra-arterial nicardipine in patients with acute ischemic stroke.

Authors:  Qaisar A Shah; Alexandros Georgiadis; M Fareed K Suri; Gustavo Rodriguez; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.